Validation study of postoperative liver failure and mortality risk scores after liver resection for perihilar cholangiocarcinoma
- PMID: 35693403
- PMCID: PMC9186189
- DOI: 10.21037/hbsn-20-660
Validation study of postoperative liver failure and mortality risk scores after liver resection for perihilar cholangiocarcinoma
Abstract
Background: Surgery for perihilar cholangiocarcinoma (PHCC) remains a challenging procedure with high morbidity and mortality. The Academic Medical Center (Amsterdam UMC) and Memorial Sloan Kettering Cancer Center proposed a postoperative mortality risk score (POMRS) and post-hepatectomy liver failure score (PHLFS) to predict patient outcomes. This study aimed to validate the POMRS and PHLFS for PHCC patients at Hokkaido University.
Methods: Medical records of 260 consecutive PHCC patients who had undergone major hepatectomy with extrahepatic bile duct resection without pancreaticoduodenectomy at Hokkaido University between March 2001 and November 2018 were evaluated to validate the PHLFS and POMRS.
Results: The observed risks for PHLF were 13.7%, 24.5%, and 39.8% for the low-risk, intermediate-risk, and high-risk groups, respectively, in the study cohort. A receiver-operator characteristic (ROC) analysis revealed that the PHLFS had moderate predictive value, with an analysis under the curve (AUC) value of 0.62. Mortality rates based on the POMRS were 1.7%, 5%, and 5.1% for the low-risk, intermediate-risk, and high-risk groups, respectively. The ROC analysis demonstrated an AUC value of 0.58.
Conclusions: This external validation study showed that for PHLFS the threshold for discrimination in an Eastern cohort was reached (AUC >0.6), but it would require optimization of the model before use in clinical practice is acceptable. The POMRS were not applicable in the eastern cohort. Further external validation is recommended.
Keywords: Perihilar cholangiocarcinoma (PHCC); post operative mortality score; post-hepatectomy liver failure score (PHLFS); validation study.
2022 Hepatobiliary Surgery and Nutrition. All rights reserved.
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-20-660/coif). TMvG serves as an unpaid Deputy Editor-in-Chief of Hepatobiliary Surgery and Nutrition. The other authors have no conflicts of interest to declare.
Comment in
-
The efficiency of postoperative liver failure and mortality risk scores after liver resection for perihilar cholangiocarcinoma.Hepatobiliary Surg Nutr. 2022 Aug;11(4):643-644. doi: 10.21037/hbsn-22-228. Hepatobiliary Surg Nutr. 2022. PMID: 36016736 Free PMC article. No abstract available.
Similar articles
-
Risk prediction of post-hepatectomy liver failure in patients with perihilar cholangiocarcinoma.J Gastroenterol Hepatol. 2018 Apr;33(4):958-965. doi: 10.1111/jgh.13966. Epub 2018 Jan 26. J Gastroenterol Hepatol. 2018. PMID: 28843035
-
Postoperative Liver Failure Criteria for Predicting Mortality after Major Hepatectomy with Extrahepatic Bile Duct Resection.Dig Surg. 2019;36(2):158-165. doi: 10.1159/000486906. Epub 2018 Feb 8. Dig Surg. 2019. PMID: 29421802
-
Risk factors of posthepatectomy liver failure for perihilar cholangiocarcinoma: Risk score and significance of future liver remnant volume-to-body weight ratio.J Surg Oncol. 2020 Sep;122(3):469-479. doi: 10.1002/jso.25974. Epub 2020 May 18. J Surg Oncol. 2020. PMID: 32424895
-
Meta-analysis of the efficacy of preoperative biliary drainage in patients undergoing liver resection for perihilar cholangiocarcinoma.Eur J Radiol. 2020 Apr;125:108897. doi: 10.1016/j.ejrad.2020.108897. Epub 2020 Feb 13. Eur J Radiol. 2020. PMID: 32114333
-
Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) procedure for cholangiocarcinoma.Int J Surg. 2020 Oct;82S:97-102. doi: 10.1016/j.ijsu.2020.06.045. Epub 2020 Jul 7. Int J Surg. 2020. PMID: 32645441 Review.
Cited by
-
Nomogram based on liver stiffness and spleen area with ultrasound for posthepatectomy liver failure: A multicenter study.World J Gastroenterol. 2024 Jul 21;30(27):3314-3325. doi: 10.3748/wjg.v30.i27.3314. World J Gastroenterol. 2024. PMID: 39086747 Free PMC article.
-
Application of ultrasound elastography and splenic size in predicting post-hepatectomy liver failure: Unveiling new clinical perspectives.World J Gastroenterol. 2025 Jan 28;31(4):98886. doi: 10.3748/wjg.v31.i4.98886. World J Gastroenterol. 2025. PMID: 39877707 Free PMC article.
-
Multivariable prognostic models for post-hepatectomy liver failure: An updated systematic review.World J Hepatol. 2025 Apr 27;17(4):103330. doi: 10.4254/wjh.v17.i4.103330. World J Hepatol. 2025. PMID: 40308827 Free PMC article.
-
Chemotherapy combined with targeted therapy and immunotherapy is an option in advanced biliary tract cancer.Therap Adv Gastroenterol. 2024 Feb 26;17:17562848241234509. doi: 10.1177/17562848241234509. eCollection 2024. Therap Adv Gastroenterol. 2024. PMID: 38415196 Free PMC article. No abstract available.
-
The efficiency of postoperative liver failure and mortality risk scores after liver resection for perihilar cholangiocarcinoma.Hepatobiliary Surg Nutr. 2022 Aug;11(4):643-644. doi: 10.21037/hbsn-22-228. Hepatobiliary Surg Nutr. 2022. PMID: 36016736 Free PMC article. No abstract available.
References
-
- Mizuno T, Ebata T, Nagino M. Advanced hilar cholangiocarcinoma: An aggressive surgical approach for the treatment of advanced hilar cholangiocarcinoma: Perioperative management, extended procedures, and multidisciplinary approaches. Surg Oncol 2020;33:201-6. 10.1016/j.suronc.2019.07.002 - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources